-
-
-
Jakarta, Indonesia
How a single drug class is rewriting the treatment paradigm for heart failure, sleep apnea, and chronic kidney disease
Dr. Melvin Andrean
A three-phase pathogenetic framework — from Trojan horse cellular entry and Schwann cell dedifferentiation to the immunological rheostat that determines the tuberculoid-lepromatous spectrum
dr. Aulia Rahmah
From routes of bacterial entry to the tuberculous granuloma — understanding how Mycobacterium tuberculosis invades, colonizes, and destroys the skin
Arum Novia Ratri, MD
How the durability limits of transcatheter bioprostheses, the complexity of valve-in-valve reintervention, and the expanding low-risk surgical evidence are reshaping aortic valve replacement decisions in patients under sixty
Orlensia Lie, MD